Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection

Treatment of upper eyelid retraction rel

Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections

✍ Sung Jun Lee, Tyler Hyung Taek Rim, Sun Young Jang, Chan Yun Kim, Dong Yeob Shin 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 580 KB

Subconjunctival injection of triamcinolo

Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series

✍ Chee, E; Chee, S-P 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Comparative study of Botox® injection tr

Comparative study of Botox® injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage

✍ Costa, P G; Saraiva, F P; Pereira, I C; Monteiro, M L R; Matayoshi, S 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Botulinum toxin A injections improve apr

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Masato Kanazawa; Takayoshi Shimohata; Masahisa Sato; Osamu Onodera; Keiko Tanaka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Botulinum Toxin A Injections Improve Apraxia of Eyelid Opening without Overt Blepharospasm Associated with Neurodegenerative Diseases Apraxia of eyelid opening (AEO) designates an intermittent inability to open the eyes voluntarily. 1 AEO is observed in patients with neurodegenerative diseases, incl

Botulinum toxin A injections improve apr

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Eva Lopez Valdes; Ignacio Javier Posada Rodriguez; Rafael Bilbao-Calabuig 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Reply: Botulinum toxin A injections impr

Reply: Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

✍ Masato Kanazawa; Takayoshi Shimohata; Masatoyo Nishizawa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var